MTCH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.09110506688148E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.634600E-04 |
Normal-vs-Stage2 |
2.03819999999855E-05 |
Normal-vs-Stage3 |
5.68212144003155E-12 |
Normal-vs-Stage4 |
9.99200722162641E-16 |
Stage1-vs-Stage2 |
4.123500E-03 |
Stage1-vs-Stage3 |
3.83900000000548E-06 |
Stage1-vs-Stage4 |
4.60560001247501E-09 |
Stage2-vs-Stage3 |
6.926000E-01 |
Stage2-vs-Stage4 |
2.130200E-01 |
Stage3-vs-Stage4 |
2.423800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63336011382853E-12 |
Normal-vs-AfricanAmerican |
1.264420E-01 |
Normal-vs-Asian |
6.399600E-01 |
Caucasian-vs-AfricanAmerican |
5.184400E-02 |
Caucasian-vs-Asian |
1.833810E-01 |
AfricanAmerican-vs-Asian |
2.492800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.72186742431313E-12 |
Normal-vs-Female |
7.32339999753862E-09 |
Male-vs-Female |
1.930640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.118970E-01 |
Normal-vs-Age(41-60Yrs) |
8.65939999705745E-08 |
Normal-vs-Age(61-80Yrs) |
1.50879309046559E-12 |
Normal-vs-Age(81-100Yrs) |
1.381410E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.318400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.951000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.094400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.449830E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.170020E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.781800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.321750E-01 |
Normal-vs-Grade 2 |
1.448480E-04 |
Normal-vs-Grade 3 |
1.30895294603306E-13 |
Normal-vs-Grade 4 |
1.11022302462516E-16 |
Grade 1-vs-Grade 2 |
1.018290E-02 |
Grade 1-vs-Grade 3 |
1.165390E-04 |
Grade 1-vs-Grade 4 |
5.40800004777964E-09 |
Grade 2-vs-Grade 3 |
2.224100E-04 |
Grade 2-vs-Grade 4 |
9.09350372779727E-11 |
Grade 3-vs-Grade 4 |
3.809500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.255200E-03 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
2.17910023359025E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.47708536910341E-12 |
Normal-vs-N1 |
4.28470000000125E-05 |
N0-vs-N1 |
3.691700E-02 |
|
|